Consilient Health joins the Sustainable Medicines Partnership
YewMaker, the executive lead of the Sustainable Medicines Partnership (SMP), is announcing that Consilient Health has joined as a founding Collaborator.
The SMP is a not-for-profit private-public collaboration executing projects to make the use of medicines more sustainable and less wasteful.
Consilient Health is a medium sized pharmaceutical company with a rich heritage of commercialising products in complex markets and therapeutic areas. Environmental and sustainable initiatives are integral to Consilient Health’s business strategy, as part of our commitment to ‘Being a Responsible Business.
““In its collaboration with SMP, Consilient Health will be working across several projects that will help to reduce the carbon footprint and waste of medicines for both Consilient Health and the NHS, by providing data, practical insights, and expertise. We are delighted to be part
of this collaboration.”
“We are very pleased Consilient Health have joined the SMP, their deep knowledge of medicine supply chains has already been invaluable. Together we will be harnessing data to identify where the greatest opportunities for reducing avoidable waste of medicines lie, and
piloting solutions.”
Posted 29/09/22
-End
Contacts:
YewMaker: comms@yewmaker.com
Consilient Health: kpulley@consilienthealth.com:
About the Sustainable Medicines Partnership
The SMP is a not-for-profit, private-public, multi-stakeholder collaboration. Through executing priority actions, the Sustainable Medicines Partnership aims to stop the avoidable waste of medicines and medicines packaging - reducing healthcare emissions and increasing health equity globally. Learn more at www.yewmaker.com/smp
About YewMaker
YewMaker builds science-based, scalable concepts and solutions that make healthcare more sustainable. YewMaker is the initiator and executive lead of the Sustainable Medicines Partnership. Learn more at www.yewmaker.com
About Consilient Health
Consilient Health is a pharmaceutical company, focused on bringing medicines that address unmet clinical needs to patients in the United Kingdom and Europe. The Company is headquartered in Ireland, with operations in UK, Sweden, and additional partnerships in Europe. Our current focus is women’s health, endocrinology, bone health and urology. In the UK, within endocrinology, we have a focus on bone health with a range of prescription medicines that address vitamin D deficiency. In women’s health, the Consilient Health range of oral contraceptives offer quality products, significant savings for the NHS and comprehensive support programmes for medical professionals and patients. In urology we have a medicine for bladder pain syndrome/interstitial cystitis. We continue to focus on building our range of medicines. Learn more at www.consilienthealth.com
